HDAC9 and neoplasm: After immunotherapy (After Tumor), the activated pathways in the tumor were mainly related to epigenetic modification such as RMTs methylate histone arginine, HDAC deacetylate histones, PRC2 methylates histones and DNA, SIRT1 negatively regulating rRNA expression, and DNA methylation.